Hims & Hers Health, Inc. (HIMS)

USD 28.55

(-8.26%)

EBITDA Summary of Hims & Hers Health, Inc.

  • Hims & Hers Health, Inc.'s latest annual EBITDA in 2023 was -19.93 Million USD , up 60.89% from previous year.
  • Hims & Hers Health, Inc.'s latest quarterly EBITDA in 2024 Q3 was 22.37 Million USD , up 82.36% from previous quarter.
  • Hims & Hers Health, Inc. reported an annual EBITDA of -61.22 Million USD in 2022, up 44.61% from previous year.
  • Hims & Hers Health, Inc. reported an annual EBITDA of -110.96 Million USD in 2021, down -553.2% from previous year.
  • Hims & Hers Health, Inc. reported a quarterly EBITDA of 12.9 Million USD for 2024 Q1, up 471.48% from previous quarter.
  • Hims & Hers Health, Inc. reported a quarterly EBITDA of 15.3 Million USD for 2024 Q2, up 13.71% from previous quarter.

Annual EBITDA Chart of Hims & Hers Health, Inc. (2023 - 2018)

Historical Annual EBITDA of Hims & Hers Health, Inc. (2023 - 2018)

Year EBITDA EBITDA Growth
2023 -19.93 Million USD 60.89%
2022 -61.22 Million USD 44.61%
2021 -110.96 Million USD -553.2%
2020 -14.08 Million USD 76.6%
2019 -74.15 Million USD -12941.21%
2018 - USD 0.0%

Peer EBITDA Comparison of Hims & Hers Health, Inc.

Name EBITDA EBITDA Difference
Church & Dwight Co., Inc. 1.25 Billion USD 101.585%
Colgate-Palmolive Company 4.5 Billion USD 100.442%
The Clorox Company 736 Million USD 102.709%
Coty Inc. 1 Billion USD 101.986%
The Estée Lauder Companies Inc. 2.4 Billion USD 100.829%
e.l.f. Beauty, Inc. 188.31 Million USD 110.588%
Edgewell Personal Care Company 285.4 Million USD 106.986%
Grove Collaborative Holdings, Inc. -21.29 Million USD 6.364%
Kimberly-Clark Corporation 3.06 Billion USD 100.65%
Kenvue Inc. 3.17 Billion USD 100.628%
Nu Skin Enterprises, Inc. 137.65 Million USD 114.484%
The Procter & Gamble Company 23.84 Billion USD 100.084%
Spectrum Brands Holdings, Inc. 323.9 Million USD 106.156%